Pantoprazole also comes in granules that you mix with apple juice or applesauce before taking it by mouth.Pantoprazole reduces the amount of acid your stomach produces, resulting in a less acidic ...

In the ECHO and THRIVE trials, 10% of the patients who received rilpivirine-based regimens experienced treatment failure. Nearly half of these patients developed resistance to multiple ...

Proton pump inhibitors (PPIs) reduce or inhibit the production of stomach acid, which relieves symptoms of acid reflux and gastroesophageal reflux disease (GERD). These medications are available ...

Since the start of 2012, the drug rilpivirine has been available for adults with an HIV-1 infection in two different forms: as a single agent and as a fixed combination with other HIV drugs. There ...

Two randomized trials indicate that the non-nucleoside reverse transcriptase inhibitor rilpivirine is noninferior to efavirenz in treatment-naive patients with HIV, with an improved safety profile.

Long-acting injectable formulations are being developed for cabotegravir, which is an integrase strand-transfer inhibitor (INSTI), and rilpivirine, which is a nonnucleoside reverse-transcriptase ...

Bottom Line: Proton pump inhibitor (PPI) use was associated with worse outcomes in patients with urothelial cancer treated with the immunotherapeutic atezolizumab (Tecentriq), compared with ...

Cabenuva injection is a 2-drug co-packaged product that combines cabotegravir, an HIV integrase strand transfer inhibitor, and rilpivirine, an HIV non-nucleoside reverse transcriptase inhibitor.